
November 25, 2017 - By Marguerite Chambers
Greenleaf Trust increased Westpac Banking Adr (WBK) stake by 105.48% reported in 2017Q2 SEC filing. Greenleaf Trust acquired 14,736 shares as Westpac Banking Adr (WBK)’s stock declined 10.65%. The Greenleaf Trust holds 28,707 shares with $672,000 value, up from 13,971 last quarter. Westpac Banking Adr now has $81.11B valuation. The stock decreased 0.29% or $0.07 on November 24, reaching $24.14. About 96,833 shares traded. Westpac Banking Corp (ADR) (NYSE:WBK) has risen 6.51% since November 25, 2016 and is uptrending. It has underperformed by 10.19% the S&P500. Vitamin Shoppe Incorporated (NYSE:VSI) had an increase of 8.06% in short interest. VSI’s SI was 4.17M shares in November as released by FINRA. Its up 8.06% from 3.86M shares previously. With 474,800 avg volume, 9 days are for Vitamin Shoppe Incorporated (NYSE:VSI)’s short sellers to cover VSI’s short positions. The SI to Vitamin Shoppe Incorporated’s float is 20.37%. The stock increased 1.33% or $0.05 on November 24, reaching $3.8. About 194,783 shares traded. Vitamin Shoppe Inc (NYSE:VSI) has declined 57.70% since November 25, 2016 and is downtrending. It has underperformed by 74.40% the S&P500.Vitamin Shoppe, Inc. is a multi-channel specialty retailer and contract maker of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The company has market cap of $91.11 million. The Firm operates through three divisions: retail, direct and manufacturing. It currently has negative earnings. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.Among 11 analysts covering Vitamin Shoppe (NYSE:VSI), 1 have Buy rating, 2 Sell and 8 Hold. Therefore 9% are positive. Vitamin Shoppe had 26 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of Vitamin Shoppe Inc (NYSE:VSI) has “Hold” rating given on Thursday, May 11 by Gabelli. Barclays Capital maintained Vitamin Shoppe Inc (NYSE:VSI) rating on Thursday, November 9. Barclays Capital has “Equal-Weight” rating and $3 target. The company was upgraded on Saturday, August 8 by Zacks. The firm has “Hold” rating by Deutsche Bank given on Thursday, November 5. Morgan Stanley maintained Vitamin Shoppe Inc (NYSE:VSI) on Thursday, August 10 with “Equal-Weight” rating. Deutsche Bank maintained Vitamin Shoppe Inc (NYSE:VSI) rating on Thursday, August 6. Deutsche Bank has “Hold” rating and $41 target. The rating was maintained by Morgan Stanley on Monday, October 2 with “Equal-Weight”. Deutsche Bank maintained it with “Hold” rating and $7 target in Thursday, August 10 report. The stock has “Sell” rating by Goldman Sachs on Thursday, January 19. The stock has “Neutral” rating by JP Morgan on Thursday, October 27.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



(adsbygoogle = window.adsbygoogle || []).push({});
